Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126146131 | 12614613 | 1 | I | 20110131 | 20150920 | 20160802 | 20160802 | EXP | CA-PFIZER INC-3035356 | PFIZER | 39.00 | YR | M | Y | 0.00000 | 20160802 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126146131 | 12614613 | 1 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, FREQ: 1 WEEK, INTERVAL: 1 | UNK | 0 | 50 | MG | /wk | ||||||
| 126146131 | 12614613 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 12.5 MG, FREQ: 1 WEEK, INTERVAL: 1 | UNK | 11719 | 12.5 | MG | /wk | ||||||
| 126146131 | 12614613 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 25 MG, UNK | 11719 | 25 | MG | SOLUTION FOR INJECTION | |||||||
| 126146131 | 12614613 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 20 UNK, UNK | 11719 | 20 | MG | SOLUTION FOR INJECTION | ||||||||
| 126146131 | 12614613 | 5 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 500 MG, UNK | UNK | 7073 | 500 | MG | TABLET | ||||||
| 126146131 | 12614613 | 6 | C | ALEVE | NAPROXEN SODIUM | 1 | UNK, SINGLE | 0 | TABLET | ||||||||||
| 126146131 | 12614613 | 7 | C | ARAVA | LEFLUNOMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | TABLET | ||||||||
| 126146131 | 12614613 | 8 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 | TABLET | ||||||||||
| 126146131 | 12614613 | 9 | C | VIMOVO | ESOMEPRAZOLE MAGNESIUMNAPROXEN | 1 | 500 MG, UNK | 0 | 500 | MG | TABLET | ||||||||
| 126146131 | 12614613 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 126146131 | 12614613 | 11 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 200 MG, UNK | 0 | 200 | MG | TABLET | ||||||||
| 126146131 | 12614613 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 5 MG, FREQ: 1 DAY, INTERVAL: 1 | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126146131 | 12614613 | 6 | Product used for unknown indication |
| 126146131 | 12614613 | 7 | Product used for unknown indication |
| 126146131 | 12614613 | 8 | Product used for unknown indication |
| 126146131 | 12614613 | 9 | Product used for unknown indication |
| 126146131 | 12614613 | 10 | Product used for unknown indication |
| 126146131 | 12614613 | 11 | Product used for unknown indication |
| 126146131 | 12614613 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126146131 | 12614613 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126146131 | 12614613 | Arthralgia | |
| 126146131 | 12614613 | Arthropathy | |
| 126146131 | 12614613 | Back pain | |
| 126146131 | 12614613 | C-reactive protein abnormal | |
| 126146131 | 12614613 | Condition aggravated | |
| 126146131 | 12614613 | Crepitations | |
| 126146131 | 12614613 | Dermatitis allergic | |
| 126146131 | 12614613 | Drug dose omission | |
| 126146131 | 12614613 | Fatigue | |
| 126146131 | 12614613 | Feeling abnormal | |
| 126146131 | 12614613 | Hepatic steatosis | |
| 126146131 | 12614613 | Joint injury | |
| 126146131 | 12614613 | Joint swelling | |
| 126146131 | 12614613 | Lymphadenopathy | |
| 126146131 | 12614613 | Musculoskeletal pain | |
| 126146131 | 12614613 | Musculoskeletal stiffness | |
| 126146131 | 12614613 | Pain | |
| 126146131 | 12614613 | Pain in extremity | |
| 126146131 | 12614613 | Pleuritic pain | |
| 126146131 | 12614613 | Rash | |
| 126146131 | 12614613 | Red blood cell sedimentation rate abnormal | |
| 126146131 | 12614613 | Rheumatoid arthritis | |
| 126146131 | 12614613 | Rheumatoid nodule | |
| 126146131 | 12614613 | Tenderness | |
| 126146131 | 12614613 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126146131 | 12614613 | 1 | 20080424 | 0 |